News Room

After going through the FDA validation process, BeCare Link received FDA approval

BeCare Link Cleared for FDA-Class I Classification

By /
Image of smart phone and features that were evaluated by the FDA validation processat were evaluated by FDA

In 2021, BeCare App was granted FDA approval for marketing to US users without additional regulatory requirements. 

The BeCare MS Link mobile app is available to the general public, including all activities, questionnaires, and healthcare provider features. The unique app received Class I classification in 2021. However, the proprietary EDSS scoring is currently only available for use in an academic/research setting, but it will be released to the public pending FDA clearance. As of 2022, the application for Class II classification has been submitted to the FDA.

Please contact us if you are interested in using our technology as part of a study at your institution.